HLA-DMB (− 69.7-fold) belongs to the major histocompatibility complex class II genes, and higher HLA-DMB expression was associated with higher survival rate via increased CD8 lymphocyte numbers in advanced-stage serous ovarian cancer (Callahan et al. 2008). Here, HLA-DMB is linked to ovarian serous adenocarcinoma.